Youngbo Chem (014440) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Youngbo Chem KRW 4,401, price KRW 4,695, upside -6.3%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Youngbo Chem for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 2,615 KRW – 5,441 KRW · fair‑value band 3,916 KRW – 5,503 KRW · the 4,695 KRW price screens above the 4,401 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Youngbo Chem in your weekly email
Every Wednesday you see whether Youngbo Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artilon, epilon, filmy, and youngboard polyolefin foam products.
Show more
Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artilon, epilon, filmy, and youngboard polyolefin foam products. Its products are used in various applications, including automotive Material Parts, including instrumental panels, bumper protector, door trim, head liner, foam duct, PP board, pillar trim, evaporator insulation, sun visor, water shield, PE pad, and console armrest cover; Electronic Material Parts, such as mobile tap, TV and monitor sealing, panel protection sheet, packaging semiconductor components, metal plating sealing shielding, solar module sealing and fixing tape, pipe insulation, and home appliances molded products; and other industry products comprises insulation, packing supplies, packaging cushioning material, automative emblem guide, sports goods water play equipment, sports goods protector, sports goods cold weather supplies, mats, household goods, footwear, industrial tape, and medical accessary tape. The company was founded in 1979 and is headquartered in Chungju-si, South Korea.
Stock analysis
Youngbo Chem (014440) currently trades at 4,695 KRW, while our model-based Fair Value estimate is 4,401 KRW, implying the stock looks roughly 6.7% fairly valued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 14,118 KRW per share, and 20 of the 24 models we run sit above the 4,695 KRW price.
Bear case: the Dividend Discount group reads lowest at 2,606 KRW, and 4 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: 3,916 KRW (bear) to 5,503 KRW (bull), the price of 4,695 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Youngbo Chem reported revenue of 120B KRW in FY2025 versus 99.7B KRW in FY2021, a compound +4.8%/yr. Reported net income was 16.8B KRW in FY2025, compounding +48.1%/yr from FY2021.
Key figures
Market cap 91.6B KRW (≈ $67.3M) · P/S ratio 0.72 · Dividend yield 7.5% · Net margin 14.0% · Return on equity 8.9% · Return on assets (EBIT) 5.7% · Operating margin 11.1% · Revenue (TTM) 122B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 6% below its 52-week high and 15% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −27% fair-value upside, at −6%, 014440 screens cheaper than that median.
Fair Value models
Bear 3,916 KRWFair Value 4,401 KRWBull 5,503 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.45/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
Start year 2020 (pandemic). Over 10 years: −2.7% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+55.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+48.1%
Dividend (yield on the price)7.5%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 16%
2025 sits 152% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Revenue per share shrinking 3.3%/yr over ~6Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +1.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 352 stocks
Beats the industry median on 10/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−6% · Above median
Profitability
Return on equity (TTM)9% · Above median
Return on assets6% · Top 25%
Net margin (TTM)13% · Top 25%
Operating margin (TTM)11% · Above median
Growth and dividend
Revenue growth8% · Above median
Dividend yield (TTM)7.5% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Youngbo Chem Fair Value". https://www.fairvalue-calculator.com/stock/014440
Frequently asked questions
Is Youngbo Chem (014440) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 4,401 KRW versus a price of 4,695 KRW, about −6% upside (fairly valued).
What is the fair value of 014440?
Our model-based fair value for Youngbo Chem is 4,401 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 4,695 KRW.
What is the quality score of 014440?
Youngbo Chem has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Youngbo Chem (014440)?
Our model-based price target is the fair value of 4,401 KRW (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 3,916 KRW, optimistic scenario 5,503 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Youngbo Chem stock forecast for 2026?
Our models put fair value at 4,401 KRW, about −6% upside versus a price of 4,695 KRW (fairly valued). Cautious scenario 3,916 KRW, optimistic scenario 5,503 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Youngbo Chem (014440)?
Youngbo Chem reported trailing-twelve-month revenue of about 122B KRW (latest available figure, as of Sep 24, 2026).
Does Youngbo Chem pay a dividend?
Youngbo Chem currently shows a dividend yield of about 7.45% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Youngbo Chem (014440)?
For today's price to be fair in a discounted-cash-flow model, Youngbo Chem would have to grow free cash flow by +3.3 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 014440 use?
Our models discount Youngbo Chem at 11.6 %: a base by market capitalisation (micro), damped by beta 0.45, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Youngbo Chem that is +3.3 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Youngbo Chem (014440) delivered so far?
Over the past 5 years revenue at Youngbo Chem grew +2.3 % a year. The price currently implies +3.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Youngbo Chem (014440) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Youngbo Chem (+3.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Youngbo Chem (014440)?
The free-cash-flow yield on the price is 8.53 %: that much free cash flow Youngbo Chem produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Youngbo Chem (014440)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Youngbo Chem it is 4,401 KRW per share (as of Sep 24, 2026), against a price of 4,695 KRW. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Youngbo Chem stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 014440 trades above its calculated fair value: price 4,695 KRW, fair value 4,401 KRW, a gap of about −6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 014440?
No. The price is what the market pays today (4,695 KRW); the fair value is what the company's own numbers justify (4,401 KRW). For Youngbo Chem the two are 293.53 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Youngbo Chem worth?
The market values Youngbo Chem at about 91.6B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 4,695 KRW; our models calculate a fair value of 4,401 KRW per share.
What do the bullish and bearish scenarios say about 014440?
Our models span a range for Youngbo Chem: cautious scenario 3,916 KRW, base 4,401 KRW, optimistic 5,503 KRW per share (as of Sep 24, 2026, price 4,695 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Youngbo Chem (014440)?
Balance-sheet figures for Youngbo Chem (as of Sep 24, 2026): return on equity 8.9%, debt of 0.01 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is 014440 from its 52-week high?
Youngbo Chem trades at 4,695 KRW, about 6% below its 52-week high of 5,020 KRW and 15% above the low of 4,085 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 4,401 KRW is for.
Which stocks are comparable to Youngbo Chem?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Ningxia Baofeng Energy Group, Dow Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Youngbo Chem stock attractive at the current price?
The data as of Sep 24, 2026: price 4,695 KRW, calculated fair value 4,401 KRW (−6%), Quality Score 60/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 014440 calculated?
We run Youngbo Chem through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4,401 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Youngbo Chem itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Youngbo Chem (014440)?
The closing price on Sep 23, 2026 was 4,695 KRW. Our model-based fair value is 4,401 KRW, about −6% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Youngbo Chem right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Youngbo Chem
How large is the market capitalisation of Youngbo Chem (014440)?
The market capitalisation of Youngbo Chem is 91.6B KRW (≈ $67.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Youngbo Chem (014440)?
The price-to-sales ratio of Youngbo Chem is 0.72 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Youngbo Chem (014440)?
The dividend yield of Youngbo Chem is 7.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Youngbo Chem (014440)?
The net margin of Youngbo Chem is 14.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Youngbo Chem (014440)?
The return on equity (ROE) of Youngbo Chem is 8.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Youngbo Chem (014440)?
On an EBIT basis the return on assets of Youngbo Chem is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Youngbo Chem (014440)?
The operating margin of Youngbo Chem is 11.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Youngbo Chem (014440)?
Revenue at Youngbo Chem is growing +7.5% versus a year earlier (3y avg +13.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Youngbo Chem (014440)?
Earnings per share at Youngbo Chem are growing −10.9% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Youngbo Chem in the live analysis
One click puts Youngbo Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
